A new session of the BioMatch Series, a program initiated in SIP for the purpose of promoting transfer and transformation of biomedical technologies from universities, was held at Oxford Suzhou Centre for Advanced Research, SIP recently, setting a bridge for cross-border collaboration between British and Chinese organizations in commercializing cutting-edge biomedical and health technologies.

At the event, eight sci-tech innovation achievements from domestic and overseas higher education institutions, such as 3D printing for medical purposes and AI-powered magnetocardiogram-based diagnosis, were presented, demonstrating remarkable innovations and commercial potentials.

Experts from Oxford University Innovation Suzhou, Jinyi Medical Tech and several investment organizations shared insights on the achievements from the perspectives such as market prospect, cross-border commercialization models, and attraction to investors.

The event also included an introduction to the Regional University-Industry Technology Transfer Center for Biopharmaceuticals (Suzhou, Jiangsu), one of the organizers of the event, focusing on its service system for cross-border technology transfer and transformation.

May 14, 2026